Pulse Biosciences closes $60M rights offering at $10/unit, oversubscribed 138%

PULSE BIOSCIENCES, INC.

Raised $60M gross from 6M units; each unit = 1 share + 2 warrants to buy 0.5 share at $11.
Subscriptions exceeded $83M from 800+ accounts, including Executive Chairman Robert Duggan.
Post-offering shares outstanding: 61,228,332; warrants for up to ~6M additional shares issued.
Proceeds to fund CellFX nsPFA products: Percutaneous Electrode, Cardiac Clamp, 360° Catheter.
Warrants exercisable immediately for 5 years; redeemable if stock exceeds $16.50 or $22 for 20 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.